Insulet Corporation to Present at Upcoming Investor Conferences

BEDFORD, MA--(Marketwire - Nov 7, 2011) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following investor conferences:

• The Brean Murray, Carret & Co. 2011 Life Sciences Summit at the Grand Hyatt in New York City. Management is scheduled to present an overview of the Company on Monday, November 14 at 2:30 p.m. ET.

• The Lazard 2011 8^th Annual Healthcare Conference at The Pierre Hotel in New York City. Management is scheduled to present an overview of the Company on Tuesday, November 15 at 2:00 p.m. ET.

• The Stephens Fall Investment Conference at the New York Palace in New York City. Management is scheduled to present an overview of the Company on Wednesday, November 16 at 10:00 a.m. ET.

• The Piper Jaffray 23^rd Annual Healthcare Conference at the New York Palace in New York City. Management is scheduled to present an overview of the Company on Tuesday, November 29 at 1:30 p.m. ET.

During the presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to audio webcasts of the presentations during the event, please visit: http://investors.insulet.com. A replay of each webcast will be available for 10 days after the initial presentation.

About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: http://www.myomnipod.com.